Ethyl 4-oxo-3,4-dihydroquinazoline-2-carboxylate, 98.0%, 250mg

1-Bromo-4-(isopropylsulfonyl)benzene, 95.0%, 5g

Seringue microlitre GASTIGHT® série 1700 Point type 3, 500 µl, 1750 RNR, 1 pièce

(11bR)-4-mercapto-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepin, 98%, 1g

tert-Butyl-4-(isoquinolin-5-yl)piperazine-1-carboxylate, 97%, 1g

Potassium iodide, 98.0%, 1kg

N-[4-(chloromethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine hydrochloride, 95.0%, 250mg

Pipéridine, PEPTIPURE®, min 99,5 %, pour la synthèse peptidique, 500 ml, conditionnement en verre

TERT-BUTYL (1-(4-HYDROXYPHENYL)ETHYL)CARBAMATE, 95.0%, 250mg

Fil d'aluminium 99,95% 0,5 mm diamètre 100 m

tert-Butyl 3-(ethylamino)azetidine-1-carboxylate, 95.0%, 1g

Methyl Phenyl Carbonate>95.0%(HPLC)25g

N-Boc-2-(4'-Chlorophenyl)-L-glycine, 95.0%, 100mg